Singapore, Nov. 14 -- Mylan N.V. and Pfizer Inc. have announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris (pronounced 'vi?-tr?s).

Deriving its name from Latin, Viatris embodies the new company's goal of providing a path-"VIA"-to three-"TRIS"-core goals: expanding access to medicines, leading by innovating to meet patient needs, and being a trusted partner for the healthcare community worldwide.

"We wanted a name that would differentiate our new company and clearly explain how we will be a champion for global health," said Robert J. Coury, who will serve as Executive Chairman of the new company, as previously announced. "We are creating a company un...